Global GMP Cytokines Industry Growth and Trends Forecast to 2031

Summary

Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.

GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.

According to APO Research, The global GMP Cytokines market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for GMP Cytokines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for GMP Cytokines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for GMP Cytokines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of GMP Cytokines include Miltenyi Biotec, Bio-Techne, Cytiva, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological and Creative Bioarray, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GMP Cytokines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Cytokines.

The GMP Cytokines market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GMP Cytokines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

GMP Cytokines Segment by Company

Miltenyi Biotec
Bio-Techne
Cytiva
Lonza
CellGenix
ReproCELL
PeproTech
Sino Biological
Creative Bioarray
Akron Biotech
Almog

GMP Cytokines Segment by Type

TNF
Interleukin
Growth Factor
Others

GMP Cytokines Segment by Application

Cell/Gene Therapy
Tissue-Engineered Products
Others

GMP Cytokines Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Cytokines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Cytokines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Cytokines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Cytokines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of GMP Cytokines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global GMP Cytokines Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global GMP Cytokines Sales Estimates and Forecasts (2020-2031)
1.3 GMP Cytokines Market by Type
1.3.1 TNF
1.3.2 Interleukin
1.3.3 Growth Factor
1.3.4 Others
1.4 Global GMP Cytokines Market Size by Type
1.4.1 Global GMP Cytokines Market Size Overview by Type (2020-2031)
1.4.2 Global GMP Cytokines Historic Market Size Review by Type (2020-2025)
1.4.3 Global GMP Cytokines Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America GMP Cytokines Sales Breakdown by Type (2020-2025)
1.5.2 Europe GMP Cytokines Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific GMP Cytokines Sales Breakdown by Type (2020-2025)
1.5.4 South America GMP Cytokines Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa GMP Cytokines Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 GMP Cytokines Industry Trends
2.2 GMP Cytokines Industry Drivers
2.3 GMP Cytokines Industry Opportunities and Challenges
2.4 GMP Cytokines Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by GMP Cytokines Revenue (2020-2025)
3.2 Global Top Players by GMP Cytokines Sales (2020-2025)
3.3 Global Top Players by GMP Cytokines Price (2020-2025)
3.4 Global GMP Cytokines Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global GMP Cytokines Major Company Production Sites & Headquarters
3.6 Global GMP Cytokines Company, Product Type & Application
3.7 Global GMP Cytokines Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global GMP Cytokines Market CR5 and HHI
3.8.2 Global Top 5 and 10 GMP Cytokines Players Market Share by Revenue in 2024
3.8.3 2023 GMP Cytokines Tier 1, Tier 2, and Tier 3
4 GMP Cytokines Regional Status and Outlook

4.1 Global GMP Cytokines Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global GMP Cytokines Historic Market Size by Region
4.2.1 Global GMP Cytokines Sales in Volume by Region (2020-2025)
4.2.2 Global GMP Cytokines Sales in Value by Region (2020-2025)
4.2.3 Global GMP Cytokines Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global GMP Cytokines Forecasted Market Size by Region
4.3.1 Global GMP Cytokines Sales in Volume by Region (2026-2031)
4.3.2 Global GMP Cytokines Sales in Value by Region (2026-2031)
4.3.3 Global GMP Cytokines Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 GMP Cytokines by Application

5.1 GMP Cytokines Market by Application
5.1.1 Cell/Gene Therapy
5.1.2 Tissue-Engineered Products
5.1.3 Others
5.2 Global GMP Cytokines Market Size by Application
5.2.1 Global GMP Cytokines Market Size Overview by Application (2020-2031)
5.2.2 Global GMP Cytokines Historic Market Size Review by Application (2020-2025)
5.2.3 Global GMP Cytokines Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America GMP Cytokines Sales Breakdown by Application (2020-2025)
5.3.2 Europe GMP Cytokines Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific GMP Cytokines Sales Breakdown by Application (2020-2025)
5.3.4 South America GMP Cytokines Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa GMP Cytokines Sales Breakdown by Application (2020-2025)
6 Company Profiles

6.1 Miltenyi Biotec
6.1.1 Miltenyi Biotec Comapny Information
6.1.2 Miltenyi Biotec Business Overview
6.1.3 Miltenyi Biotec GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Miltenyi Biotec GMP Cytokines Product Portfolio
6.1.5 Miltenyi Biotec Recent Developments
6.2 Bio-Techne
6.2.1 Bio-Techne Comapny Information
6.2.2 Bio-Techne Business Overview
6.2.3 Bio-Techne GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Techne GMP Cytokines Product Portfolio
6.2.5 Bio-Techne Recent Developments
6.3 Cytiva
6.3.1 Cytiva Comapny Information
6.3.2 Cytiva Business Overview
6.3.3 Cytiva GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cytiva GMP Cytokines Product Portfolio
6.3.5 Cytiva Recent Developments
6.4 Lonza
6.4.1 Lonza Comapny Information
6.4.2 Lonza Business Overview
6.4.3 Lonza GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lonza GMP Cytokines Product Portfolio
6.4.5 Lonza Recent Developments
6.5 CellGenix
6.5.1 CellGenix Comapny Information
6.5.2 CellGenix Business Overview
6.5.3 CellGenix GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CellGenix GMP Cytokines Product Portfolio
6.5.5 CellGenix Recent Developments
6.6 ReproCELL
6.6.1 ReproCELL Comapny Information
6.6.2 ReproCELL Business Overview
6.6.3 ReproCELL GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ReproCELL GMP Cytokines Product Portfolio
6.6.5 ReproCELL Recent Developments
6.7 PeproTech
6.7.1 PeproTech Comapny Information
6.7.2 PeproTech Business Overview
6.7.3 PeproTech GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PeproTech GMP Cytokines Product Portfolio
6.7.5 PeproTech Recent Developments
6.8 Sino Biological
6.8.1 Sino Biological Comapny Information
6.8.2 Sino Biological Business Overview
6.8.3 Sino Biological GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sino Biological GMP Cytokines Product Portfolio
6.8.5 Sino Biological Recent Developments
6.9 Creative Bioarray
6.9.1 Creative Bioarray Comapny Information
6.9.2 Creative Bioarray Business Overview
6.9.3 Creative Bioarray GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Creative Bioarray GMP Cytokines Product Portfolio
6.9.5 Creative Bioarray Recent Developments
6.10 Akron Biotech
6.10.1 Akron Biotech Comapny Information
6.10.2 Akron Biotech Business Overview
6.10.3 Akron Biotech GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Akron Biotech GMP Cytokines Product Portfolio
6.10.5 Akron Biotech Recent Developments
6.11 Almog
6.11.1 Almog Comapny Information
6.11.2 Almog Business Overview
6.11.3 Almog GMP Cytokines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Almog GMP Cytokines Product Portfolio
6.11.5 Almog Recent Developments
7 North America by Country

7.1 North America GMP Cytokines Sales by Country
7.1.1 North America GMP Cytokines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America GMP Cytokines Sales by Country (2020-2025)
7.1.3 North America GMP Cytokines Sales Forecast by Country (2026-2031)
7.2 North America GMP Cytokines Market Size by Country
7.2.1 North America GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America GMP Cytokines Market Size by Country (2020-2025)
7.2.3 North America GMP Cytokines Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe GMP Cytokines Sales by Country
8.1.1 Europe GMP Cytokines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe GMP Cytokines Sales by Country (2020-2025)
8.1.3 Europe GMP Cytokines Sales Forecast by Country (2026-2031)
8.2 Europe GMP Cytokines Market Size by Country
8.2.1 Europe GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe GMP Cytokines Market Size by Country (2020-2025)
8.2.3 Europe GMP Cytokines Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific GMP Cytokines Sales by Country
9.1.1 Asia-Pacific GMP Cytokines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific GMP Cytokines Sales by Country (2020-2025)
9.1.3 Asia-Pacific GMP Cytokines Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific GMP Cytokines Market Size by Country
9.2.1 Asia-Pacific GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific GMP Cytokines Market Size by Country (2020-2025)
9.2.3 Asia-Pacific GMP Cytokines Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America GMP Cytokines Sales by Country
10.1.1 South America GMP Cytokines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America GMP Cytokines Sales by Country (2020-2025)
10.1.3 South America GMP Cytokines Sales Forecast by Country (2026-2031)
10.2 South America GMP Cytokines Market Size by Country
10.2.1 South America GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America GMP Cytokines Market Size by Country (2020-2025)
10.2.3 South America GMP Cytokines Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa GMP Cytokines Sales by Country
11.1.1 Middle East and Africa GMP Cytokines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa GMP Cytokines Sales by Country (2020-2025)
11.1.3 Middle East and Africa GMP Cytokines Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa GMP Cytokines Market Size by Country
11.2.1 Middle East and Africa GMP Cytokines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa GMP Cytokines Market Size by Country (2020-2025)
11.2.3 Middle East and Africa GMP Cytokines Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 GMP Cytokines Value Chain Analysis
12.1.1 GMP Cytokines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 GMP Cytokines Production Mode & Process
12.2 GMP Cytokines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 GMP Cytokines Distributors
12.2.3 GMP Cytokines Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings